AlloVir Inc. is a leading clinical-stage biopharmaceutical company focused on developing innovative cell therapies to treat and prevent viral diseases. With a diverse pipeline, including therapies targeting COVID-19, the company aims to revolutionize the medical landscape through its cutting-edge research and development efforts.
